Transcatheter Embolization and Occlusion Devices Market

    The global transcatheter embolization and occlusion devices market is expected to exceed US$ 4.5 billion by 2024, registering a compound annual growth rate (CAGR) of more than 7.5% during the forecast period. The rising prevalence of cancer and increasing approval of minimally invasive surgeries are expected to drive the transcatheter embolization and occlusion devices market. However, the high cost of products and lack of skilled professionals are hampering the growth of the transcatheter embolization and occlusion devices market.

    In this report, the global transcatheter embolization and occlusion devices market is segmented by product, application, end user, and region. On the basis of product, the market is segmented into embolization coils, embolization particles, coiling assist devices, flow diverter devices, liquid embolics, and accessories. The embolization coils, embolization particles, and accessories segments are further divided into various sub segments. The market on the basis of application is segmented into peripheral vascular disease, neurology, oncology, urology, and others. On the basis of end user, the market is segmented into hospitals, ambulatory surgical centers, and clinics.

    The global transcatheter embolization and occlusion devices market is segmented on the basis of key regions, namely, North America, Europe, Asia Pacific, and Rest of the World. Furthermore, each region is segmented to provide market revenue for select countries such as the U.S., Canada, the U.K., Germany, China, Japan, India, Brazil, and GCC countries. The report includes a detailed study of the global and regional transcatheter embolization and occlusion devices market and analyzes the variations in the growth of the industry in certain regions.

    St. Jude Medical, Inc., Abbott Laboratories, Medtronic plc, BTG plc, Boston Scientific Corporation, Cook Medical, Inc., Edwards Lifesciences, Johnson & Johnson, Merit Medical Systems, Inc., Penumbra, Inc., Pfizer, Inc., Sirtex Medical Limited, Stryker Corporation, and Terumo Corporation are the most active players in the transcatheter embolization and occlusion devices market.

    A glimpse of the report structure is provided in the report description available on the website.

    https://www.marketresearchengine.com/reportdetails/transcatheter-embolization-and-occlusion-devices-market

    This report covers the transcatheter embolization and occlusion devices market, in terms of value, and forecasts the market size till 2024. In addition, the report identifies key growth segments and opportunities in the industry. This report also covers detailed competitive outlook including the share and company profiles of the key players in the global transcatheter embolization and occlusion devices market. Company profile includes company summary, financial summary, business strategy and planning, SWOT analysis, and current developments.

    The deep-dive study on the transcatheter embolization and occlusion devices market will help customers with identifications of new market opportunities and targeted promotional plans.

     

    Media Contact

    Company Name: Market Research Engine

    Contact Person: John Bay

    Email: john@marketresearchengine.com

    Phone: +1-855-984-1862

    Country: United States

    Website: https://www.marketresearchengine.com/

     

     

    Source: http://www.financeswire.com/global-transcatheter-embolization-and-occlusion-devices-market-to-reach-us-4-5-billion-by-2024